Balance between Pro- and Antifibrotic Proteins in Mesenchymal Stromal Cell Secretome Fractions Revealed by Proteome and Cell Subpopulation Analysis.
Maria A KulebyakinaNataliya BasalovaDaria ButuzovaMikhail ArbatskyVadim ChechekhinNatalia I KalininaPyotr A Tyurin-KuzminKonstantin Y KulebyakinOleg I KlychnikovAnastasia Yu EfimenkoPublished in: International journal of molecular sciences (2023)
Multipotent mesenchymal stromal cells (MSCs) regulate tissue repair through paracrine activity, with secreted proteins being significant contributors. Human tissue repair commonly results in fibrosis, where fibroblast differentiation into myofibroblasts is a major cellular mechanism. MSCs' paracrine activity can inhibit fibrosis development. We previously demonstrated that the separation of MSC secretome, represented by conditioned medium (CM), into subfractions enriched with extracellular vesicles (EV) or soluble factors (SF) boosts EV and SF antifibrotic effect. This effect is realized through the inhibition of fibroblast-to-myofibroblast differentiation in vitro. To unravel the mechanisms of MSC paracrine effects on fibroblast differentiation, we performed a comparative proteomic analysis of MSC secretome fractions. We found that CM was enriched in NF-κB activators and confirmed via qPCR that CM, but not EV or SF, upregulated NF-κB target genes ( COX2 , IL6 , etc.) in human dermal fibroblasts. Furthermore, we revealed that EV and SF were enriched in TGF-β, Notch, IGF, and Wnt pathway regulators. According to scRNAseq, 11 out of 13 corresponding genes were upregulated in a minor MSC subpopulation disappearing in profibrotic conditions. Thus, protein enrichment of MSC secretome fractions and cellular subpopulation patterns shift the balance in fibroblast-to-myofibroblast differentiation, which should be considered in studies of MSC paracrine effects and the therapeutic use of MSC secretome.
Keyphrases
- endothelial cells
- single cell
- bone marrow
- transforming growth factor
- signaling pathway
- stem cells
- pi k akt
- mesenchymal stem cells
- cell proliferation
- pulmonary fibrosis
- cell therapy
- genome wide
- gene expression
- induced pluripotent stem cells
- transcription factor
- lps induced
- binding protein
- umbilical cord
- pluripotent stem cells
- mass spectrometry
- extracellular matrix
- immune response
- protein protein